A Dose Of The Moderna Vaccine Will Cost Americans $25-30
The American biotechnology company Moderna intends to sell one dose of the coronavirus vaccine for $25-30, a course of vaccinations will cost $50-60, according to the FT citing sources close to the company's negotiations with possible buyers of the vaccine.
According to the publication's interlocutors, such a price can be set for the markets of the United States and other countries with a high level of income for residents. According to the newspaper, Moderna's competitors in developing a coronavirus vaccine offer lower prices. American Pfizer and German BioNTtech intend to sell 100 million doses to the United States for $19.5, British-Swedish AstraZeneca announced the price of a dose of the vaccine at $3-4.
Moderna, at the beginning of the week, started the third phase of clinical trials of the COVID-19 vaccine. It will be attended by 30,000 volunteers. This is one of the world's largest clinical trials of the vaccine. According to the FT, at a hearing in the US Congress a week earlier, representatives of Moderna, Pfizer, and Merck said that they intend to profit from the vaccine. AstraZeneca and Johnson & Johnson, on the other hand, indicated that they would not seek to profit from the sale of their vaccines if they were proven effective in the early stages of using it in a pandemic.
Earlier, the world health organization called for joint efforts to develop drugs, tests, and vaccines designed to counter COVID-19. Politicians, activists, and government officials have expressed concern that poor countries will be left out of the fight for access to vaccines and medicines, as opposed to higher-income countries.